Onchocerciasis Treatment Industry Insights: Market Forecast to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Onchocerciasis Treatment Market Size Likely To Evolve From 2025 Through 2034?

The onchocerciasis treatment market size has shown substantial growth recently. It is forecast to increase from $1.03 billion in 2024 to $1.11 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.8%. The expansion observed historically can be linked to a rise in individuals experiencing eye-related conditions, an uptick in parasitic infections, an increase in the availability of targeted treatment centers, a surge in awareness campaigns, and an expanding older population.

The onchocerciasis treatment market is projected to experience substantial expansion in the coming years. It is forecast to reach $1.48 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 7.5%. This anticipated growth is driven by factors such as an increasing incidence in affected areas, a greater need for surgical interventions, improvements in healthcare facilities, a rising occurrence of long-term illnesses, and increased spending in the healthcare sector. Key trends during this period are expected to encompass the adoption of single-dose treatments, progress in macrocyclic lactone formulations, the introduction of therapies aimed at Wolbachia, the incorporation of artificial intelligence (AI) into drug development, and the creation of treatments specifically for children.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24634&type=smp

Which Drivers Are Shaping The Onchocerciasis Treatment Industry’s Market Share?

An increase in individuals experiencing eye-related problems is anticipated to fuel the expansion of the onchocerciasis treatment market in the future. These problems encompass various conditions impacting sight and eye well-being, such as infections, injuries, and persistent diseases like glaucoma or cataracts. The rise in patients with eye conditions primarily stems from increased screen usage and extended contact with digital screens. Onchocerciasis therapy assists in averting and handling vision impairment and blindness in affected individuals by eradicating the parasitic infection responsible for inflammation and harm to eye tissues. For example, as reported in May 2024 by the Centers for Disease Control and Prevention (CDC), a US-based public health agency, approximately 20.5 million Americans aged over 40 suffer from cataracts in at least one eye, representing 17.2% of that demographic. Furthermore, projections indicate that close to 30 million individuals will develop cataracts by 2028. Consequently, the growing occurrence of eye-related ailments is stimulating the expansion of the onchocerciasis treatment market.

What Are The Major Segments Identified In The Onchocerciasis Treatment Market?

The onchocerciasis treatment market covered in this report is segmented –

1) By Drug Type: Ivermectin, Doxycycline, Albendazole, Moxidectin

2) By Treatment Strategy: Mass Drug Administration (MDA), Targeted Treatment

3) By Mode Of Administration: Oral, Injectables, Topical

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End User: Hospitals And Clinics, Home Care Settings, Government And Non-Governmental Programs

Subsegments:

1) By Ivermectin: Oral Tablets, Community-Based Mass Drug Administration (MDA) Kits, Fixed-Dose Combination Therapies, Pediatric Formulations

2) By Doxycycline: Oral Capsules, Extended-Release Tablets, Combination With Anti-Wolbachia Therapy, Hospital-Based Prescription Treatments

3) By Albendazole: Single-Dose Oral Tablets, Combination Therapy With Ivermectin, Government-Supplied Preventive Chemotherapy Packages, Over-The-Counter (OTC) Formulations In Endemic Areas

4) By Moxidectin: Oral Tablets, Long-Acting Formulations, Adult-Only Dosing Regimens, Clinical Trial-Based Access Programs

What Trends Are Redefining The Onchocerciasis Treatment Market Dynamics?

Major companies operating in the onchocerciasis treatment market are concentrating on developing new antiparasitic medications to enhance treatment effectiveness and decrease its duration. Antiparasitic medications are drugs engineered to eliminate or suppress parasites, such as worms and protozoa, which cause human infections. For example, in December 2024, Medicines Development for Global Health (MDGH), an Australia-based non-profit biopharmaceutical company, obtained approval from the Ghana Food and Drugs Authority (FDA) for Moxidectin 2 mg oral tablets to treat river blindness in individuals aged 4 years and older. This approval empowers Ghana to implement community-based mass drug administration programs using moxidectin, which provides superior efficacy and more enduring effects compared to ivermectin. With this approval, MDGH aims to broaden access to an effective new onchocerciasis treatment, facilitating large-scale community initiatives in endemic regions.

Which Key Players Are Driving Competition In The Onchocerciasis Treatment Market?

Major companies operating in the onchocerciasis treatment market are Merck & Co. Inc., Teva Pharmaceutical Industries Limited, Hetero Labs Limited, Sun Pharmaceutical Industries Limited, Intas Pharmaceuticals Limited, Dr. Reddy’s Laboratories Inc., Cipla Limited, Endo Inc., Lupin Limited, Instituto de Tecnologia em Imunobiológicos Bio-Manguinhos – Fundação Oswaldo Cruz (Fiocruz), AMGIS Lifescience Ltd., Drugs for Neglected Diseases initiative (DNDi), Rakshit Drugs Pvt. Ltd., Hangzhou Longshine Bio-Tech Co. Ltd., OREX Pharma Private Limited, Angle Bio Pharma Pvt. Ltd., Senores Pharmaceuticals Inc., Avenacy LLC, Dolphin Pharma, Cerata Pharmaceuticals Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/onchocerciasis-treatment-global-market-report

What Regional Growth Trends Are Shaping The Onchocerciasis Treatment Market Outlook?

North America was the largest region in the onchocerciasis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the onchocerciasis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Onchocerciasis Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24634&type=smp

Browse Through More Reports Similar to the Global Onchocerciasis Treatment Market 2025, By The Business Research Company

Oncology Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oncology-drugs-global-market-report

Oncology Companion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oncology-companion-diagnostics-global-market-report

Oncologists Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oncologists-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795